Processa Pharmaceuticals, Inc.

PCSA

Processa Pharmaceuticals, Inc.

PCSA

Insider Sentiment (TTM):

Last Purchase:2026-06-15Last Sale:-Shares Purchased (TTM):67,324Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:177,706Shares Outstanding:2,623,143Institutional Ownership Pct.:6.77%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash And Cash Equivalents At Carrying Value	0	2	6	6	7	3	1	3	6	9	5	7
Assets Current
Assets Current	2	2	6	7	7	4	2	5	7	10	6	8
Other Receivables Net Current	-	-	-	-	-	-	-	-	-	0	-	-
Prepaid Expense And Other Assets Current	1	0	0	0	0	1	1	2	2	1	1	1
Security Deposit	-	-	-	-	-	-	-	0	0	0	-	0
Crypto Asset Fair Value	0	2	1	-	-	-	-	-	-	-	-	-
Other Assets Noncurrent
Other Assets Noncurrent	-	-	-	-	-	-	-	-	-	-	0	0
Prepaid Expense Noncurrent	-	1	1	1	1	1	1	-	-	-	-	-
Assets Noncurrent
Assets Noncurrent	-	-	-	-	-	-	1	-	-	-	-	-
Property Plant And Equipment Net	0	0	0	0	-	-	0	0	0	0	0	0
Assets	2	5	8	8	8	5	3	5	8	10	6	8
Operating Lease Liability Current	-	-	-	-	-	-	-	-	-	-	0	0
Other Assets
Other Assets	-	-	-	-	0	0	0	-	-	-	0	-
Liabilities And Stockhold…
Operating Lease Right Of Use Asset	-	-	-	-	0	0	0	-	-	-	0	0
Assets Noncurrent Other Than Noncurrent Investment…	-	-	-	-	0	0	0	0	0	0	0	-
Accounts Payable Current	2	1	1	1	1	1	1	1	1	0	0	0
Other Liabilities Current	-	-	-	-	-	-	-	-	-	-	0	0
Liabilities Current
Liabilities Current	2	2	2	2	2	1	2	1	2	1	1	1
Accrued Liabilities Current	1	1	1	1	1	1	1	0	1	0	0	0
Operating Lease Liability Noncurrent	-	-	-	-	-	-	-	-	-	-	0	0
Liabilities	2	2	2	2	2	1	2	1	2	1	1	1
Liabilities Noncurrent
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	107	107	107	104	100	94	89	89	87	87	81	80
Stockholders Equity
Stockholders Equity	-0	3	6	6	6	4	2	4	6	9	5	7
Treasury Stock Value	-	-	-0	-0	-0	-0	-0	-0	-0	-0	-0	-0
Retained Earnings Accumulated Deficit	-107	-104	-101	-97	-94	-90	-87	-84	-81	-78	-75	-73
Liabilities And Stockholders Equity	2	5	8	8	8	5	3	5	8	10	6	8
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	-	-	-	0	-
Preferred Stock Shares Authorized	1	1	1	1	1	1	1	-	-	-	1	-
Preferred Stock Shares Issued	0	0	0	0	0	0	0	-	-	-	0	-
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	-	-	-	0	-
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	1,000	1,000	1,000	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	3	3	57	2	2	0	0	0	0	0	0	0
Shares Outstanding	3	3	57	2	2	0	0	0	0	0	0	0
Treasury Stock Common Shares	-	-	0	0	0	0	0	0	0	0	0	0

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-10.80%	-35.19%	-9.41%	-	-	-	-	-	-	-	-	-
2025	6.93%	-28.47%	-11.31%	-18.18%	-7.79%	34.20%	-18.04%	-50.38%	-58.73%	-12.34%	-13.61%	-20.25%
2024	-29.19%	7.18%	-20.10%	-5.88%	-12.50%	-15.44%	-35.34%	-36.09%	-39.25%	-41.41%	-43.76%	-29.18%
2023	-	-	-	-	-	-	101.85%	-16.14%	-67.86%	-	-	-
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.87	0.98	2.54	3.76	3.45	2.93	1.23	3.97	4.82	9.70	7.71	9.57
Quick Ratio	0.28	0.85	2.48	3.60	3.34	2.26	0.78	2.37	3.59	8.85	6.44	8.31
Working Capital	-320.55K	-41.69K	3.43M	4.84M	5.08M	2.47M	346.52K	3.62M	5.93M	8.79M	4.90M	7.08M
Leverage & Debt
Debt to Equity	-7.52	0.78	0.40	0.30	0.34	0.36	0.90	0.33	0.26	0.12	0.16	0.13
Debt Ratio	1.15	0.44	0.29	0.23	0.25	0.27	0.47	0.25	0.21	0.11	0.14	0.11
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-4.89	-5.38	-10.36	-6.80	-20.49	-31.98	-96.78	-87.96	-85.67	-99.59	-211.99	-402.33
Free Cash Flow Per Share TTM	-4.35	-4.67	-8.70	-5.65	-17.26	-31.90	-91.87	-84.89	-77.79	-81.10	-153.75	-156.27
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	4.32%	17.97%	14.46%	12.21%	26.00%	21.70%	6.55%	-46.95%	-60.17%	-65.18%	-59.45%	23.49%
EPS Growth (1Y)	-76.15%	-83.18%	-89.30%	-92.27%	-76.09%	-67.89%	-54.34%	-78.14%	-82.02%	-83.93%	-75.09%	-25.92%
Valuation Metrics
P/E TTM	-0.39	-0.47	-0.28	-0.71	-0.25	-0.29	-0.23	-0.39	-0.65	-0.59	-0.79	-0.31
P/B TTM	-16.64	2.61	0.68	1.56	0.53	0.98	1.60	1.21	1.11	0.66	1.76	0.94
Market Cap	5.28M	6.62M	3.77M	9.12M	3.22M	3.46M	2.71M	4.49M	6.68M	5.83M	8.79M	6.75M
Enterprise Value	5.09M	4.93M	-1.77M	2.82M	-3.71M	562.12K	1.51M	1.60M	1.11M	-3.09M	4.08M	-109.73K
Calculated Values
Free Cash Flow TTM	-11.97M	-12.25M	-11.39M	-10.73M	-10.85M	-11.93M	-11.25M	-11.12M	-9.28M	-8.00M	-8.07M	-8.44M
Net Debt	-196.33K	-1.69M	-5.54M	-6.31M	-6.94M	-2.90M	-1.19M	-2.89M	-5.57M	-8.92M	-4.71M	-6.86M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-06-15Purchase

Owner: Guy, Wendy

Title: Chief Administrative Officer

Shares: 2,118

Price/Share: $2.22

Value: $4,701.96

Shares Owned: 11,958

Relationship: Officer

Ownership: Direct

2026-06-15Purchase

Owner: Skibsted, Russell

Title: Chief Financial Officer

Shares: 2,654

Price/Share: $2.22

Value: $5,891.88

Shares Owned: 13,412

Relationship: Officer

Ownership: Direct

2026-06-15Purchase

Owner: Young, David

Title: Pres. Research & Development

Shares: 2,067

Price/Share: $2.22

Value: $4,588.74

Shares Owned: 19,198

Relationship: Director,Officer

Ownership: Direct

2026-06-15Purchase

Owner: Ng, George K

Title: Chief Executive Officer

Shares: 2,465

Price/Share: $2.22

Value: $5,472.30

Shares Owned: 12,435

Relationship: Director,Officer

Ownership: Direct

2026-06-15Purchase

Owner: Lin, Patrick

Title: Chief Business - Strategy Off

Shares: 1,831

Price/Share: $2.22

Value: $4,064.82

Shares Owned: 11,007

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-06-15	Guy, Wendy	Officer	Chief Administrative Officer	Direct	Purchase	2,118	2.22	$4,701.96	11,958	4
2026-06-15	Skibsted, Russell	Officer	Chief Financial Officer	Direct	Purchase	2,654	2.22	$5,891.88	13,412	4
2026-06-15	Young, David	Director,Officer	Pres. Research & Development	Direct	Purchase	2,067	2.22	$4,588.74	19,198	4
2026-06-15	Ng, George K	Director,Officer	Chief Executive Officer	Direct	Purchase	2,465	2.22	$5,472.30	12,435	4
2026-06-15	Lin, Patrick	Officer	Chief Business - Strategy Off	Direct	Purchase	1,831	2.22	$4,064.82	11,007	4
2026-05-29	Skibsted, Russell	Officer	Chief Financial Officer	Direct	Purchase	2,292	2.57	$5,890.44	10,758	4
2026-05-29	Lin, Patrick	Officer	Chief Business - Strategy Off	Direct	Purchase	1,582	2.57	$4,065.74	9,176	4
2026-05-29	Young, David	Director,Officer	Pres. Research & Development	Direct	Purchase	1,786	2.57	$4,590.02	17,131	4
2026-05-29	Guy, Wendy	Officer	Chief Administrative Officer	Direct	Purchase	1,829	2.57	$4,700.53	9,840	4
2026-05-29	Ng, George K	Director,Officer	Chief Executive Officer	Direct	Purchase	2,129	2.57	$5,471.53	9,970	4
2026-05-15	Skibsted, Russell	Officer	Chief Financial Officer	Direct	Purchase	1,984	2.97	$5,892.48	8,466	4
2026-05-15	Young, David	Director,Officer	Pres. Research & Development	Direct	Purchase	1,545	2.97	$4,588.65	15,345	4
2026-05-15	Guy, Wendy	Officer	Chief Administrative Officer	Direct	Purchase	1,583	2.97	$4,701.51	8,011	4
2026-05-15	Ng, George K	Director,Officer	Chief Executive Officer	Direct	Purchase	1,843	2.97	$5,473.71	7,841	4
2026-05-15	Lin, Patrick	Officer	Chief Business - Strategy Off	Direct	Purchase	1,369	2.97	$4,065.93	7,594	4
2026-04-30	Lin, Patrick	Officer	Chief Business - Strategy Off	Direct	Purchase	1,511	2.69	$4,064.59	6,236	4
2026-04-30	Bigora, Sian	Officer	Chief Development Officer	Direct	Purchase	1,971	2.71	$5,341.41	7,481	4/A
2026-04-30	Guy, Wendy	Officer	Chief Administrative Officer	Direct	Purchase	1,748	2.69	$4,702.12	6,441	4
2026-04-30	Skibsted, Russell	Officer	Chief Financial Officer	Direct	Purchase	2,190	2.69	$5,891.10	6,498	4
2026-04-30	Ng, George K	Director,Officer	Chief Executive Officer	Direct	Purchase	2,034	2.69	$5,471.46	6,013	4
2026-04-30	Young, David	Director,Officer	Pres. Research & Development	Direct	Purchase	1,706	2.69	$4,589.14	13,813	4
2026-04-15	Guy, Wendy	Officer	Chief Administrative Officer	Direct	Purchase	1,583	2.97	$4,701.51	4,693	4
2026-04-15	Ng, George K	Director,Officer	Chief Executive Officer	Direct	Purchase	1,843	2.97	$5,473.71	3,979	4/A
2026-04-15	Lin, Patrick	Officer	Chief Business - Strategy Off	Direct	Purchase	1,369	2.97	$4,065.93	4,725	4
2026-04-15	Bigora, Sian	Officer	Chief Development Officer	Direct	Purchase	1,799	2.97	$5,343.03	5,510	4
2026-04-15	Skibsted, Russell	Officer	Chief Financial Officer	Direct	Purchase	1,984	2.97	$5,892.48	4,308	4
2026-04-15	Young, David	Director,Officer	Pres. Research & Development	Direct	Purchase	1,545	2.97	$4,588.65	12,107	4
2026-03-31	Bigora, Sian	Officer	Chief Development Officer	Direct	Purchase	2,107	2.54	$5,351.78	3,711	4
2026-03-31	Guy, Wendy	Officer	Chief Administrative Officer	Direct	Purchase	1,854	2.54	$4,709.16	3,110	4
2026-03-31	Skibsted, Russell	Officer	Chief Financial Officer	Direct	Purchase	2,324	2.54	$5,902.96	2,324	4
2026-03-31	Pannu, Geraldine	Director	-	Direct	Purchase	2,072	2.54	$5,262.88	2,188	4
2026-03-31	Ng, George K	Director,Officer	Chief Executive Officer	Direct	Purchase	2,136	2.54	$5,425.44	2,136	4/A
2026-03-31	Young, David	Director,Officer	Pres. Research & Development	Direct	Purchase	1,810	2.54	$4,597.40	10,562	4
2026-03-31	Baluch, Khoso	Director	-	Direct	Purchase	2,269	2.54	$5,763.26	2,325	4
2026-03-31	Lin, Patrick	Officer	Chief Business - Strategy Off	Direct	Purchase	1,603	2.54	$4,071.62	3,356	4
2026-03-31	Neal, James R	Director	-	Direct	Purchase	789	2.54	$2,004.06	818	4
2025-01-27	Yorke, Justin W	Director	-	Indirect	Purchase	12,400	0.80	$9,920.00	12,400	4
2025-01-27	Young, David	Director,Officer	Pres. Research & Development	Direct	Purchase	124,500	0.80	$99,600.00	205,405	4
2025-01-27	Lin, Patrick	Officer	Chief Business - Strategy Off	Indirect	Purchase	43,500	0.80	$34,800.00	43,500	4
2025-01-27	Ng, George K	Director,Officer	Chief Executive Officer	Indirect	Purchase	87,200	0.80	$69,760.00	87,200	4
2024-02-07	Young, David	Director,Officer	Pres. Research & Development	Direct	Purchase	21,000	2.45	$51,450.00	79,387	4
2024-02-06	Young, David	Director,Officer	Pres. Research & Development	Direct	Purchase	20,000	2.53	$50,600.00	58,387	4
2024-02-01	Lin, Patrick	Officer	Chief Business - Strategy Off	Direct	Purchase	1,500	2.40	$3,600.00	27,478	4
2024-01-30	Yorke, Justin W	Director	-	Indirect	Purchase	8,000	2.69	$21,520.00	31,232	4
2024-01-30	Ng, George K	Director,Officer	Chief Executive Officer	Indirect	Purchase	10,000	2.70	$27,000.00	20,000	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

6.77%

Inst. Shares: 177,706

Shares Outstanding: 2,623,143

2025-12-31

7.29%

Inst. Shares: 95,483

Shares Outstanding: 1,309,271

2025-09-30

91.53%

Inst. Shares: 1,740,096

Shares Outstanding: 1,901,021

2025-06-30

43.03%

Inst. Shares: 267,990

Shares Outstanding: 622,772

2025-03-31

34.12%

Inst. Shares: 127,603

Shares Outstanding: 373,967

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	177,706	2,623,143	6.77%
2025-12-31	95,483	1,309,271	7.29%
2025-09-30	1,740,096	1,901,021	91.53%
2025-06-30	267,990	622,772	43.03%
2025-03-31	127,603	373,967	34.12%
2024-12-31	66,996	122,438	54.72%
2024-09-30	48,551	131,040	37.05%
2024-06-30	45,030	119,331	37.74%
2024-03-31	106,332	98,661	107.78%
2023-12-31	983,909	52,463	-
2023-09-30	1,301,104	54,008	-
2023-06-30	1,317,519	53,872	-
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Processa Pharmaceuticals, Inc. (PCSA) — SEC Financial Statements & Analysis

Processa Pharmaceuticals, Inc. (PCSA) is a pharmaceutical preparations company, incorporated in DE. Processa Pharmaceuticals, Inc. trades on Nasdaq as: PCSA. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Processa Pharmaceuticals, Inc. reported a Debt-to-Equity ratio of -7.52x, a Price-to-Book (P/B) ratio of -16.64x (TTM), at a market cap of $5.28M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: -7.52x
P/B TTM: -16.64x
Market Cap: $5.28M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Processa Pharmaceuticals, Inc. in?

Processa Pharmaceuticals, Inc. (PCSA) operates in the Pharmaceutical Preparations industry.

What is PCSA's market cap?

Processa Pharmaceuticals, Inc. (PCSA) has a market capitalization of $5.28M as of 2026-06-30.

What exchange does PCSA trade on?

Processa Pharmaceuticals, Inc. (PCSA) trades on the Nasdaq.

Where is Processa Pharmaceuticals, Inc. incorporated?

Processa Pharmaceuticals, Inc. is incorporated in DE.